Citius Oncology CTOR Income Statement (2021-2026)

NASDAQ CTOR
$0.94 +0.01 (+1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Citius Oncology Quarterly Income Statement

Periods 17 quarters
Latest Jun 2026

Citius Oncology reported revenue of $1.49M and net income of -$8.92M for the quarter ended Jun 2026. This income statement covers 17 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2021 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.73M1.73M3.21M9.02M9.02M8.94M67.50M4.74M6.65M71.55M71.55M71.55M71.55M83.51M84.80M92.98M105.76M
Revenue & cost
Revenue 3.94M1.67M1.49M
Gross Profit 3.15M1.34M1.00M
Operating items
Research & DevelopmentR&D 1.15M2.50M3.63M1.26M3.14M0.94M1.08M1.02M1.08M0.26M
Selling, General & AdministrativeSG&A 0.15M0.20M0.77M1.52M2.90M4.44M3.32M2.24M1.88M1.34M2.86M23.63M4.22M
Restructuring CostsRestructuring 0.02M0.03M0.03M0.09M0.42M0.86M1.33M0.57M0.57M0.57M0.50M0.50M0.57M1.00M
Other Operating ExpensesOther Opex 1.49M3.02M4.50M1.24M1.52M1.56M1.80M4.03M4.68M4.24M
Operating ExpensesOpex 0.02M0.18M0.23M0.86M4.58M9.27M13.90M6.39M7.47M4.94M4.71M8.41M29.95M9.72M
Operating IncomeOp. Inc -0.15M-0.20M-0.77M-0.27M-13.90M-6.39M-7.47M-4.94M-4.71M-5.25M-28.61M-8.72M
EBIT -0.15M-0.20M-0.77M-4.58M-0.27M-13.90M-6.39M-7.47M-4.94M-4.71M-5.25M-28.61M-8.72M
Non-operating items
Non Operating Interest Expenses 0.47M0.06M0.05M0.03M0.23M
Interest & Investment IncomeInt & Inv Inc 0.03M0.04M0.10M
Other Non Operating IncomeOther Non Op Inc. 1.76M
Non Operating IncomeNon Op. Inc. 0.76M0.82M2.15M0.76M0.64M-0.16M-0.02M-0.02M1.77M-0.31M
Net income details
EBT -0.15M-0.20M-0.77M-4.58M-9.27M-13.90M-6.39M-7.47M-5.11M-4.73M-5.27M-26.84M-9.03M
Tax ProvisionsTaxes 0.14M0.29M0.43M0.26M0.26M0.26M0.26M0.26M-0.23M-0.11M
Profit After TaxPAT 0.61M0.62M1.39M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M-8.92M
Income from Continuing OperationsIncome (Continuing) -0.15M-0.20M-0.77M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M-8.92M
Consolidated Net IncomeConsol Net Inc. -0.15M-0.20M-0.77M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M-8.92M
Income towards Parent CompanyParent Net Inc -0.15M-0.20M-0.77M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M-8.92M
Net Income towards Common StockholdersNet Income -0.15M-0.20M-0.77M-4.73M-9.56M-14.34M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M-8.92M
Additional items
EPS (Basic) -0.02-0.02-0.09-0.07-2.02-2.15-0.09-0.11-0.08-0.07-0.06-0.27-0.08
EPS (Diluted) -0.02-0.02-0.09-0.07-2.02-3.32-0.09-0.11-0.08-0.07-0.06-0.27-0.08
Shares Outstanding 1.73M1.50M3.21M9.02M9.02M8.94M67.50M4.74M6.65M68.05M71.55M71.55M71.55M73.27M87.46M100.03M107.89M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.50M3.21M9.02M9.02M8.94M67.50M4.74M4.31M68.05M71.55M71.55M71.55M73.27M87.46M100.03M107.89M
EBITDA -0.15M-0.20M-0.77M-4.58M-0.27M-13.90M-6.39M-7.47M-4.94M-4.71M-5.25M-28.61M-8.72M
Interest ExpensesInt Expense 0.47M0.06M0.05M0.03M0.23M
Tax Rate -3.14-3.11-3.11-4.13-3.54-5.18-5.58-5.010.861.19